Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. [electronic resource]
Producer: 20080916Description: 1539-42 p. digitalISSN:- 1528-0020
- Adolescent
- Adult
- Aged
- Child
- Child, Preschool
- Female
- Graft vs Host Disease -- diagnosis
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Incidence
- Infant
- Infant, Newborn
- Male
- Middle Aged
- Myeloablative Agonists -- therapeutic use
- Predictive Value of Tests
- Prognosis
- Receptors, Tumor Necrosis Factor, Type I -- blood
- Survival Rate
- Time Factors
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.